US Patent Issued to Eagle Pharmaceuticals on April 21 for "Methods of treating SARS-CoV-2 infections" (New Jersey Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,364, issued on April 21, was assigned to Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.).

"Methods of treating SARS-CoV-2 infections" was invented by Adrian Hepner (Woodcliff Lake, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to methods of using dantrolene or a dantrolene prodrug, or a pharmaceutically acceptable salt thereof, to treat COVID-19 and SARS-CoV-2 infections."

The patent was filed on April 8, 2021, under Application No. 17/995,602.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fs...